In colon cancer cells, Sunitinib was shown to inhibit the HIF-1 alpha translation accompanied with inactivation of Akt, possibly suggesting that Sunitinib may directly act on Akt [30, 31]. Here, AKT1 is linked to colonic neoplasm.